Michelle Hessen, OD, spoke about the results of a new study evaluating the efficacy of cyclosporine ophthalmic solution 0.09% in patients with dry eye.

Allergan's ageing Restasis, meanwhile, is also facing the threat of generic competition, so there's a lot to play for and no shortage of hopefuls aiming to break into the market. NICE backs NHS ...